Azilect

Active Ingredient(s): Rasagiline Mesylate
FDA Approved: * May 16, 2006
Pharm Company: * TEVA PHARMS
Category: Parkinsons

Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B[2] used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases.[3] The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identified it as a potential drug for Parkinson's disease, and working with collaborators at Technion– Israel Institute of Technology in Israel and the d... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
3 Discussions

Dosage List

Azilect GIL;1
Azilect 1 mg Oral Tablet
NDC: 43353-015
Labeler:
Aphena Pharma Solutions - Tennessee, LLC
Azilect GIL;0;5
Azilect 0.5 mg Oral Tablet
NDC: 68546-142
Labeler:
Teva Neuroscience, Inc.
Azilect GIL;1
Azilect 1 mg Oral Tablet
NDC: 68546-229
Labeler:
Teva Neuroscience, Inc.
Azilect GIL;1
Azilect 1 mg Oral Tablet
NDC: 54868-6206
Labeler:
Physicians Total Care, Inc.

Popular Topics

azilect

for parkinsons...